. Author manuscript; available in PMC: 2022 Oct 13.

Published in final edited form as: Sex Health. 2022 Jul 22;19(5):391–405. doi: 10.1071/SH22016

Table 2. Summary of Meta-Analysis Results.

	k	n	Effect Size			Heterogeneity			Egger’s Test
			d	95% CI	^p	Q	I²	^p	^p
All RCTs (All Outcomes)	5	582	0.23	0.037 to 0.421	.03*	4.48	10.7%	.345	.405
All RCTs (Objective)	5	582	0.19	-0.096 to 0.484	.137	5.22	23.3%	.266	.144
ART-Only RCTs (Objective)	4	461	0.1	-0.232 to 0.424	.419	2.28	0.0%	.516	.714

Note: (1) All RCTs (All Outcomes) – included all RCTs addressing antiretroviral therapy (ART) and preexposure prophylaxis (PrEP), utilised self-report, pill count and biomarker measures; (2) All RCTs (Objective) – included all RCTs addressing ART and PrEP but only utilised pill count and biomarker measures; (3) ART-Only RCTs (Objective) – excluded 1 study conducted on pre-exposure prophylaxis use and only utilised pill count and biomarker measures